Basf Se Corporation

Dabur Research Foundation

Gautam R Desiraju

Peter Erk

Gerhard Cox

Rahul Banerjee

Claude Taranta

Heidi Emilia Saxell

Prashant M Bhatt

Thomas Kröhl

Martin Sukopp

Rama Mukherjee

Manu Jaggi

Antti Ojala

Stefan Scherer

Kamal K Kapoor

Mukund Keshav Gurjar

Jhillu Singh Yadav

Anand C Burman

Anu T Singh

Thomas Kroehl

Srivari Chandrasekhar

Radhika Dilip Wakharkar

Kalapatapu V V M Sairam

Sankar Kumar Dutta

Venkatachalam Sesha Giri

Ashwini Nangia

Asish Kumar Banerjee

K V V M Sairam

Sanjay Sarkhel

Anuo T Singh

Hanumant Bapu Rao Borate

Thomas Krohl

The present invention relates to a novel crystalline modification of fipronil, to a process for the preparation of the same, to pesticidal and parasiticidal mixtures and compositions comprising said crystalline modification and to their use for combating pests and parasites.

Crystalline modification of fipronil

The present invention relates to a crystalline modification of fipronil, to a process for the preparation of the same, to pesticidal and parasiticidal mixtures and compositions comprising said crystalline modification and to their use for combating pests and parasites.

The present invention relates to a crystalline modification of fipronil, to process for the preparation of the same, to pesticidal and parasiticidal mixtures and compositions comprising said crystalline modification and to their use for combating pests and parasites.

The invention relates to the use of derivatives of cyclopentenone for the inhibition or prevention of the growth or multiplication of cancer cells, and to therapeutic compositions containing such compounds. The invention relates more specifically to the use of derivatives of cyclopentenone for the inhibition and/or prevention of cancer of the colon, pancreas, larynx, ovary, duodenum, kidney, oral cavity, prostate, lung, endothelial cells and leukemias.

Cyclopentenone derivatives for cancer therapy

The invention relates to the use of novel anthracene based compounds for the inhibition or prevention of the growth or multiplication of cancer cells, and to therapeutic compositions containing such compounds. The invention relates more specifically to the use of hydroanthracene based compounds for the inhibition and/or prevention of cancer of the colon, pancreas, prostate, lung, larynx, ovary, breast, glioblastoma, oral cavity, endothelial cells and leukemias. The agents of the invention form a distinct class, distinct from the anthracene, anthrone or anthraquinone derivatives.

Hydroanthracene based compounds as anticancer agents

Growing community of inventors

Hyderabad Telangana, India

Gautam R Desiraju